Drug-resistant infections team

We work with experts and partner organisations, including research, policy and industry experts, clinical scientists, product developers, NGOs and funders, to explore global solutions to drug-resistant infections.

Contact us

To contact the team, email drugresistantinfections@wellcome.org.

Team contacts

Tim Jinks

Head of Drug-resistant Infections Programme

Jeremy Knox

Policy and Advocacy Lead

Rebecca Sugden

Policy Adviser

Sian Williams

Policy Officer

Oliver Williams

Policy Officer

Gemma Buckland-Merrett

Science Innovation Lead

Francesca Chiara

Science Officer

Janet Midega

Science Officer

Joanna Wiecek

Science Officer

Chibuzor Uchea

Science Officer

Charlotte Chapman

Programme Manager

Janvi Patel

PA/Team Coordinator

Veronika Jacobi

Team Administrator

Our work

Drug-resistant infections: transforming the global response

The collective overuse of antibiotics has caused one of the most urgent health problems. We want to transform the world's response towards stemming the rise of drug-resistant infections.

News

A worker cleans the exterior of a train coach that has been converted into a Covid-19 isolation ward.

Opinion | 16 September 2020

Could Covid-19 be fuelling drug resistance? by Gemma Buckland Merrett

An illustration of pills.

Opinion | 13 July 2020

A lifeline for antibiotic development by Jeremy Knox

More news

Reports

Report 14 October 2019 Updated 14 July 2020

Reframing resistance

DownloadPDF 1.1MB

This report aims to guide experts, communicators and practitioners to communicate with impact, so that the public understands and supports action on drug-resistant infections.

Report 14 October 2019 Updated 14 July 2020

Reframing Resistance

[Summary] This report aims to help experts and practitioners to communicate with impact, so that the public understands and supports action on drug-resistant infections.

Briefings and responses

Consultation response 1 September 2020 Updated 15 September 2020

Response to European Medicines Agencies Network Strategy to 2025

DownloadPDF 193KB

The European Medicines Agencies Network issued a draft strategy document in July 2020, setting out a proposed strategy to guide the work of the European Medicines Agency and Heads of Medicines Agencies for the period 2021-2025 . Wellcome responded to the AMR themeatic questions within this open cons

Consultation response 1 June 2020 Updated 18 June 2020

Response to the Open Consultation on the Terms of Reference of the Independent Panel for Evidence on Action Against Antimicrobial Resistance

DownloadPDF 108KB
Consultation response Updated 26 March 2020

Response to the Indian Government on the open consultation for proposed Environment (Protection) Amendment Rules 2020

DownloadPDF 141KB

The Indian Ministry of Environment, Forest and Climate Change issued the draft notification Environment Protection Amendment Rules 2020, setting out proposed national standards for levels of antimicrobials released in pharmaceutical manufacturing effluent. As a potential driver of antimicrobial resi